- $1.91bn
- $1.69bn
- $1.04bn
- 87
- 30
- 49
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 424 | 541 | 679 | 868 | 1,040 |
Cost of Revenue | |||||
Gross Profit | 188 | 267 | 357 | 435 | 518 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 440 | 504 | 605 | 815 | 1,014 |
Operating Profit | -15.4 | 36.8 | 73.9 | 52.6 | 25.6 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.5 | 34.3 | 72.7 | 54 | 34.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.7 | 33.5 | 238 | 41 | 29.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -17.7 | 33.5 | 238 | 41 | 29.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.7 | 33.5 | 238 | 41 | 29.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.293 | 0.639 | 3.51 | 0.595 | 0.423 |